Bruce E Johnson Selected Research

Bruce E Johnson Research Topics

Disease

102	Neoplasms (Cancer) 05/2024 - 03/2002
92	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2002
39	Lung Neoplasms (Lung Cancer) 02/2024 - 05/2004
16	Adenocarcinoma of Lung 01/2023 - 06/2004
14	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 02/2002
12	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2002
11	Disease Progression 10/2017 - 06/2002
7	Brain Neoplasms (Brain Tumor) 01/2019 - 10/2005
7	Malignant Mesothelioma 01/2018 - 09/2002
5	Adenocarcinoma 12/2021 - 05/2004
4	Melanoma (Melanoma, Malignant) 02/2024 - 07/2016
4	Carcinogenesis 12/2023 - 10/2003
4	Carcinoma (Carcinomatosis) 12/2023 - 07/2003
4	Exanthema (Rash) 11/2013 - 05/2004
3	Breast Neoplasms (Breast Cancer) 05/2024 - 07/2006
3	Diarrhea 02/2024 - 09/2005
3	Nausea 02/2024 - 05/2004
3	Osteoporosis 09/2012 - 09/2007
2	Vomiting 02/2024 - 10/2017
2	Fatigue 02/2024 - 11/2013
2	Neuroblastoma 01/2024 - 02/2015
2	Dyspnea (Shortness of Breath) 12/2023 - 11/2013
2	Aneuploidy (Aneuploid) 11/2023 - 11/2023
2	Pneumonia (Pneumonitis) 01/2023 - 05/2008
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2005
2	Mesothelioma 01/2018 - 08/2008
2	Leukopenia 01/2018 - 07/2010
2	Circulating Neoplastic Cells 12/2016 - 03/2016
2	Carcinoid Tumor (Carcinoid) 11/2014 - 05/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2013 - 06/2013
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2007 - 10/2004
1	Skin Neoplasms (Skin Cancer) 02/2024
1	Inflammation (Inflammations) 12/2023

Drug/Important Bio-Agent (IBA)

45	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2002
35	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021 - 05/2005
28	Gefitinib (Iressa)FDA Link 04/2016 - 05/2004
22	Tyrosine Kinase InhibitorsIBA 03/2023 - 05/2005
16	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2006
11	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 02/2006
9	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2018
9	Paclitaxel (Taxol)FDA LinkGeneric 06/2013 - 06/2002
8	vandetanib (ZD6474)IBA 04/2016 - 09/2007
8	Phosphotransferases (Kinase)IBA 08/2015 - 06/2004
8	Carboplatin (JM8)FDA LinkGeneric 06/2013 - 05/2003
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010 - 10/2004
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2003
6	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2018
5	Docetaxel (Taxotere)FDA Link 04/2016 - 05/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 05/2005
4	atezolizumabIBA 12/2023 - 10/2022
4	AntibodiesIBA 01/2022 - 11/2008
4	Anaplastic Lymphoma KinaseIBA 03/2020 - 10/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 06/2002
4	PlatinumIBA 04/2016 - 06/2013
4	Bevacizumab (Avastin)FDA Link 09/2014 - 08/2008
4	Cetuximab (Erbitux)FDA Link 11/2013 - 08/2005
3	NucleotidesIBA 05/2024 - 09/2012
3	binimetinibIBA 02/2024 - 03/2022
3	encorafenibIBA 02/2024 - 03/2022
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 05/2007
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2023 - 02/2002
3	CrizotinibIBA 03/2020 - 03/2017
3	human ERBB2 proteinIBA 11/2017 - 02/2015
3	dabrafenibIBA 10/2017 - 01/2016
3	Monoclonal AntibodiesIBA 11/2013 - 07/2006
3	Imatinib Mesylate (Gleevec)FDA Link 05/2004 - 08/2003
2	Tumor Biomarkers (Tumor Markers)IBA 12/2023 - 03/2023
2	DNA Transposable Elements (Element, IS)IBA 12/2023 - 03/2023
2	InterleukinsIBA 12/2023 - 08/2005
2	durvalumabIBA 11/2023 - 01/2023
2	Small Cytoplasmic RNAIBA 01/2020 - 11/2018
2	Gemcitabine FDA Link 01/2018 - 06/2013
2	trametinibIBA 10/2017 - 07/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2017 - 11/2013
2	Mitogen-Activated Protein KinasesIBA 07/2016 - 05/2007
2	Discoidin Domain Receptor 2IBA 11/2013 - 06/2011
2	Dasatinib (BMS 354825)FDA Link 11/2013 - 06/2011
2	Formaldehyde (Formol)FDA Link 12/2012 - 02/2006
2	ParaffinIBA 12/2012 - 02/2006
2	Everolimus FDA Link 10/2012 - 08/2007
2	Estrogens (Estrogen)FDA Link 03/2011 - 02/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2009 - 05/2009
2	LigandsIBA 11/2008 - 11/2005
2	pertuzumabIBA 10/2007 - 07/2006
2	Zoledronic Acid (Zometa)FDA Link 10/2007 - 09/2007
2	Ectopic HormonesIBA 07/2006 - 02/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2004 - 10/2003
1	Hormones (Hormone)IBA 05/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024
1	pembrolizumabIBA 12/2023
1	canakinumab FDA Link 12/2023

Therapy/Procedure

72	Therapeutics 02/2024 - 03/2002
31	Drug Therapy (Chemotherapy) 12/2023 - 03/2002
6	Radiotherapy 11/2018 - 06/2002
4	Precision Medicine 10/2022 - 01/2018
3	Immunotherapy 11/2023 - 11/2018
3	Adjuvant Chemotherapy 09/2012 - 10/2003
2	Combination Drug Therapy (Combination Chemotherapy) 10/2013 - 08/2013
2	Aftercare (After-Treatment) 09/2009 - 11/2005
2	Pneumonectomy (Lung Volume Reduction) 08/2009 - 02/2009